BLAC   $11.13  -4.22% Market Closed

Bellevue Life Sciences Acquisition Corp
Total Cash 119.12K
totalCashPerShare 0.029
EBITDA
Total Debt 1.59M
quickRatio 0.035
currentRatio 0.049
Total Revenue
debtToEquity
Revenue/Share
ROA -0.029830001
ROE
grossProfits
freeCashflow -65.32K
operatingCashflow -1.88M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 46.13M
forwardPE
floatShares 1.78M
sharesOutstanding 4.04M
sharesShort 534.00
sharesShortPriorMonth 124.00
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.50%
heldPercentInstitutions 0.44%
Short Ratio help_outline 0.05%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -1.213
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -165.71K
trailingEps -0.04%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 18
lastUpdated Nov. 2, 2024, 4:16 a.m.